Shanghai, China

Guangwen Yang

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Guangwen Yang: Innovator in Pharmaceutical Chemistry

Introduction

Guangwen Yang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 3 patents, his work focuses on innovative solutions for drug development.

Latest Patents

Yang's latest patents include groundbreaking inventions such as "2,6-dioxaspiro [4,5] decane derivatives and preparation method therefor and pharmaceutical applications thereof." This invention relates to a series of 2,6-dioxaspiro [4,5] decane derivatives and their applications in the preparation of opiate receptor μ agonist related drugs. It specifically addresses the derivative compounds shown in formula (I), tautomers thereof, or pharmaceutically acceptable compositions thereof. Another notable patent is for a "Carboxylic acid derivative as ATR receptor antagonist." This invention pertains to a compound shown in formula (II) or a pharmaceutically acceptable salt thereof, with applications in preparing drugs for treating diseases related to angiotensin II receptor type 2 (ATR).

Career Highlights

Throughout his career, Guangwen Yang has worked with various companies, including Shandong Danhong Pharmaceutical Co., Ltd. His expertise in pharmaceutical chemistry has positioned him as a key player in the development of innovative drug solutions.

Collaborations

Yang has collaborated with notable professionals in his field, including Shuhui Chen and Wentao Wu. These collaborations have further enhanced his research and development efforts.

Conclusion

Guangwen Yang's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the industry. His work continues to pave the way for advancements in drug development and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…